135 related articles for article (PubMed ID: 32729757)
21. Nano-erythrocyte membrane-chaperoned 5-fluorouracil liposomes as biomimetic delivery platforms to target hepatocellular carcinoma cell lines.
AlQahtani SA; Harisa GI; Badran MM; AlGhamdi KM; Kumar A; Salem-Bekhit MM; Ahmad SF; Alanazi FK
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):989-996. PubMed ID: 30873877
[TBL] [Abstract][Full Text] [Related]
22. Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells.
Cheng M; Xu H; Wang Y; Chen H; He B; Gao X; Li Y; Han J; Zhang Z
Drug Des Devel Ther; 2013; 7():1287-99. PubMed ID: 24187487
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the cytotoxic effects of PLGA coated iron oxide nanoparticles as a carrier of 5- fluorouracil and mega-voltage X-ray radiation in DU145 prostate cancer cell line.
Hajikarimi Z; Khoei S; Khoee S; Mahdavi SR
IEEE Trans Nanobioscience; 2014 Dec; 13(4):403-8. PubMed ID: 25051558
[TBL] [Abstract][Full Text] [Related]
24. Polydopamine-coated liposomes as pH-sensitive anticancer drug carriers.
Zong W; Hu Y; Su Y; Luo N; Zhang X; Li Q; Han X
J Microencapsul; 2016 May; 33(3):257-62. PubMed ID: 27174396
[TBL] [Abstract][Full Text] [Related]
25. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
Li X; Xu Y; Chen G; Wei P; Ping Q
Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
[TBL] [Abstract][Full Text] [Related]
26. Chitosan-decorated and tripolyphosphate-crosslinked pH-sensitive niosomal nanogels for Controlled release of fluoropyrimidine 5-fluorouracil.
Ahmed MM; Ameen MSM; Abazari M; Badeleh SM; Rostamizadeh K; Mohammed SS
Biomed Pharmacother; 2023 Aug; 164():114943. PubMed ID: 37267634
[TBL] [Abstract][Full Text] [Related]
27. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection.
Petrilli R; Eloy JO; Saggioro FP; Chesca DL; de Souza MC; Dias MVS; daSilva LLP; Lee RJ; Lopez RFV
J Control Release; 2018 Aug; 283():151-162. PubMed ID: 29864476
[TBL] [Abstract][Full Text] [Related]
28. L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo.
Mishra BJ; Kaul A; Trivedi P
Drug Deliv; 2015 Feb; 22(2):214-22. PubMed ID: 24524408
[TBL] [Abstract][Full Text] [Related]
29. Polymeric nanoparticles for oral delivery of 5-fluorouracil: Formulation optimization, cytotoxicity assay and pre-clinical pharmacokinetics study.
Mattos AC; Altmeyer C; Tominaga TT; Khalil NM; Mainardes RM
Eur J Pharm Sci; 2016 Mar; 84():83-91. PubMed ID: 26775869
[TBL] [Abstract][Full Text] [Related]
30. Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles.
Shi WB; Le VM; Gu CH; Zheng YH; Lang MD; Lu YH; Liu JW
J Pharm Sci; 2014 Apr; 103(4):1064-74. PubMed ID: 24523221
[TBL] [Abstract][Full Text] [Related]
31. Pluronic-Coated Biogenic Gold Nanoparticles for Colon Delivery of 5-Fluorouracil: In vitro and Ex vivo Studies.
Mahdi WA; Hussain A; Ramzan M; Faruk A; Bukhari SI; Dev A
AAPS PharmSciTech; 2021 Feb; 22(2):64. PubMed ID: 33533992
[TBL] [Abstract][Full Text] [Related]
32. Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line.
Benito-Miguel M; Blanco MD; Gómez C
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):466-75. PubMed ID: 25976508
[TBL] [Abstract][Full Text] [Related]
33. Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization.
Yadav AK; Agarwal A; Jain S; Mishra AK; Bid H; Rai G; Agrawal H; Agrawal GP
J Biomed Nanotechnol; 2010 Aug; 6(4):340-50. PubMed ID: 21323107
[TBL] [Abstract][Full Text] [Related]
34. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
Leelakanok N; Geary SM; Salem AK
J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
[TBL] [Abstract][Full Text] [Related]
35. 5-Fluorouracil encapsulated alginate beads for the treatment of breast cancer.
Arica B; Caliş S; Kaş H; Sargon M; Hincal A
Int J Pharm; 2002 Aug; 242(1-2):267-9. PubMed ID: 12176261
[TBL] [Abstract][Full Text] [Related]
36. 5-Fluorouracil-Impregnated PLGA Coated Gold Nanoparticles for Augmented Delivery to Lung Cancer: In Vitro Investigations.
Gupta R; Vishwakarma L; Guleri SK; Kumar G
Anticancer Agents Med Chem; 2022; 22(12):2292-2302. PubMed ID: 34951582
[TBL] [Abstract][Full Text] [Related]
37. Formation and characterization of β-cyclodextrin (β-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug.
Prabha G; Raj V
Biomed Pharmacother; 2016 May; 80():173-182. PubMed ID: 27133054
[TBL] [Abstract][Full Text] [Related]
38. Preparation of 5-fluorouracil-loaded nanoparticles and study of interaction with gastric cancer cells.
Fan YL; Fan BY; Li Q; Di HX; Meng XY; Ling N
Asian Pac J Cancer Prev; 2014; 15(18):7611-5. PubMed ID: 25292036
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies.
Cheng M; Han J; Li Q; He B; Zha B; Wu J; Zhou R; Ye T; Wang W; Xu H; Hou Y
J Biomed Mater Res B Appl Biomater; 2012 Nov; 100(8):2035-43. PubMed ID: 22865703
[TBL] [Abstract][Full Text] [Related]
40. Cholesterol-Conjugate as a New Strategy to Improve the Cytotoxic Effect of 5-Fluorouracil on Liver Cancer: Impact of Liposomal Composition.
Alanazi SA; Harisa GI; Badran MM; Haq N; Radwan AA; Kumar A; Shakeel F; Alanazi FK
Curr Drug Deliv; 2020; 17(10):898-910. PubMed ID: 32072911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
